Introduction
In 1975, interest was raised by the identification of certain cells with lymphocyte morphology, present in both humans and mice, cells with the ability to destroy modified cells without being previously activated (1) .
The difference between B and T lymphocytes is represented by the existence of a primary entity that does not require activation (2).
Karre and colleagues introduced the "missing self" hypothesis that basically stipulates that these cells have the ability to detect and destroy cells with MHC-1 deficiency (major histocompatibility complex) (3) Depending on the density of CD16 and CD56 present on the surface, NK cells can be divided into two subpopulations: CD56 dim (moderate presence of CD56, predominantly displaying CD16 -and with high cytotoxic potential) and CD56 bright (CD16 presence greatly reduced, reduced cytotoxicity but with high cytokine production after activation) (7) . Recently, a new NK cell marker -NKp46-has been discovered in humans and mice (8, 9) . 
Discussion

 The role of NK cells in cancer
